|
1
|
Giustina A, Mazziotti G and Canalis E:
Growth hormone, insulin-like growth factor and the skeleton. Endocr
Rev. 29:535–559. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stred SE, Stubbart JR, Argetsinger LS, et
al: Stimulation by growth hormone (GH) of GH receptor-associated
tyrosine kinase activity. Endocrinology. 130:1626–1636.
1992.PubMed/NCBI
|
|
3
|
Argetsinger LS, Campbell GS, Yang X, et
al: Identification of JAK2 as a growth hormone receptor-associated
tyrosine kinase. Cell. 74:237–244. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carter-Su C, Argetsinger LS, Campbell GS,
et al: The identification of JAK2 tyrosine kinase as a signaling
molecule for growth hormone. Proc Soc Exp Biol Med. 206:210–215.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herrington J, Smit LS, Schwartz J and
Carter-Su C: The role of STAT proteins in growth hormone signaling.
Oncogene. 19:2585–2597. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gan Y, Zhang Y, Digirolamo DJ, et al:
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces
GH-induced STAT5 signaling. Mol Endocrinol. 24:644–656. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hadjidakis DJ and Androulakis II: Bone
remodeling. Ann NY Acad Sci. 1092:385–396. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zuo C, Huang Y, Bajis R, Sahih M, Li YP,
Dai K and Zhang X: Osteoblastogenesis regulation signals in bone
remodeling. Osteoporos Int. 23:1653–1663. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gazzerro E and Canalis E: Bone
morphogenetic proteins and their antagonists. Rev Endocr Metab
Disord. 7:51–65. 2006. View Article : Google Scholar
|
|
10
|
Kawabata M, Imamura T and Miyaxono K:
Signal transduction by bone morphogenetic proteins. Cytokine Growth
Factor Rev. 9:49–61. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wozney JM, Rosen V, Byrne M, Celeste AJ,
Moutsatsos I and Wang EA: Growth factor influencing bone
development. J Cell Sci Suppl. 13:149–156. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laflamme C, Curt S and Rouabhia M:
Epidermal growth factor and bone morphogenetic proteins upregulate
osteoblast proliferation and osteoblastic markers and inhibit bone
nodule formation. Arch Oral Biol. 55:689–701. 2010. View Article : Google Scholar
|
|
13
|
Sampath TK, Maliakal JC, Hauschka PV, et
al: Recombinant human osteogenic protein-1 (hOP-1) induces new bone
formation in vivo with a specific activity comparable with natural
bovine osteogenic protein and stimulates osteoblast proliferation
and differentiation in vitro. J Biol Chem. 267:20352–20356.
1992.
|
|
14
|
Vukicevic S, Luyten FP and Reddi AH:
Stimulation of the expression of osteogenic and chondrogenic
phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA.
86:8793–8797. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Buijs JT, Henriquez NV, van Overveld PG,
et al: Bone morphogenetic protein 7 in the development and
treatment of bone metastases from breast cancer. Cancer Res.
67:8742–8751. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang SN, Lapage J and Hirschberg R: Loss
of tubular bone morphogenic protein-7 in diabetic nephropathy. J Am
Soc Nephrol. 12:2392–2399. 2001.PubMed/NCBI
|
|
17
|
Kamath VG, Chandrashekar A and Rajini PS:
Antiradical properties of sorghum (Sorghum bicolor L.
Moench) flour extracts. J Cereal Sci. 40:283–288. 2004. View Article : Google Scholar
|
|
18
|
Park JH, Darvin P, Lim EJ, et al:
Hwanggeumchal sorghum induces cell cycle arrest and
suppresses tumor growth and metastasis through Jak2/STAT pathways
in breast cancer xenografts. PLoS One. 7:e405312012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park JH, Lee SH, Chung IM and Park Y:
Sorghum extract exerts an anti-diabetic effect by improving insulin
sensitivity PPAR-γ in mice fed a high-fat diet. Nutr Res Pract.
6:322–327. 2012.PubMed/NCBI
|
|
20
|
Audran M: Drug combination strategies for
osteoporosis. Joint Bone Spine. 73:374–378. 2006. View Article : Google Scholar
|
|
21
|
Turner CH: Toward a cure for osteoporosis:
reversal of excessive bone fragility. Osteoporos Int. 2:12–19.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Joung YH, Lim EJ, Darvin P, et al: MSM
enhances GH signaling via the Jak2/STAT5B pathway in
osteoblast-like cells and osteoblast differentiation through the
activation of STAT5B in MSCs. PLoS One. 7:e474772012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chung IM and Kim SH: Analysis methods of
phenol compounds. Korean Society of Crop Science. 8:5–12. 2004.
|
|
24
|
Salgado AJ, Coutinho OP and Reis RL: Bone
tissue engineering: state of the art and future trends. Macromol
Biosci. 4:743–765. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aaronson DS and Horvath CM: A road map for
those who don’t know JAK-STAT. Science. 296:1653–1655. 2002.
|
|
26
|
Canalis E, Pash J, Gabbitas B, et al:
Growth factors regulate the synthesis of insulin-like growth
factor-I in bone cell cultures. Endocrinology. 133:33–38.
1993.PubMed/NCBI
|
|
27
|
Rydziel S, Shaikh S and Canalis E:
Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance
the synthesis of PDGF-AA in bone cell cultures. Endocrinology.
134:2541–2546. 1994.PubMed/NCBI
|
|
28
|
Canalis E, Pash J and Varghese S: Skeletal
growth factors. Crit Rev Eukaryot Gene Expr. 3:155–166. 1993.
|
|
29
|
Chen D, Zhao M and Mundy GR: Bone
morphogenetic proteins. Growth Factors. 22:233–241. 2004.
View Article : Google Scholar
|
|
30
|
Boon MR, van der Horst G, van der Pluijm
G, Tamsma JT, Smit JW and Rensen PC: Bone morphogenetic protein 7:
a broad-spectrum growth factor with multiple target therapeutic
potency. Cytokine Growth Factor Rev. 22:221–229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
DiGirolamo DJ, Mukherjee A, Fulzele K, et
al: Mode of growth hormone action in osteoblasts. J Biol Chem.
282:31666–31674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nilsson A, Swolin D, Enerback S and
Ohlsson C: Expression of functional growth hormone receptors in
cultured human osteoblast-like cells. J Clin Endocrinol Metab.
80:3483–3488. 1995.PubMed/NCBI
|
|
33
|
Kassem M, Mosekilde L and Eriksen EF:
Growth hormone stimulates proliferation of normal human bone marrow
stromal osteoblast precursor cells in vitro. Growth Regul.
4:131–135. 1994.PubMed/NCBI
|
|
34
|
Huang Y, Kim SO, Yang N, Jiang J and Frank
SJ: Physical and functional interaction of growth hormone and
insulin-like growth factor-1 signaling elements. Mol Endocrinol.
18:1471–1485. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Joung YH, Lim EJ, Kim MS, et al:
Enhancement of hypoxia-induced apoptosis of human breast cancer
cells via STAT5B by momilactone B. Int J Oncol. 33:477–484.
2008.PubMed/NCBI
|
|
36
|
Park SH, Joung YH, Park JH, et al: Hypoxia
upregulates Hsp90α expression via STAT5B in cancer cells. Int J
Oncol. 41:161–168. 2012.
|
